ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2010

Jun 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2010-06-08

Reporting Person: GOLDSTEIN JACK (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-08	stock option (right to buy)	$14.20	A	738	Acquired	2020-06-08	Common Stock (738)	Direct

Footnotes

F1: The options shall vest in full on the earlier of June 8, 2011 or the date immediately prior to Oncogenex Pharmaceuticals, Inc.'s next annual meeting of stockholders.